NeuroLF Brain PET System

Organization
Positrigo AG · Switzerland
Solution Type
Ready Product / Solution
Collaboration
Marketing, Business Collaboration (Joint Venture)

1. Technology overview

Positrigo AG is a Swiss medtech company based at Technoparkstrasse 1 in Zurich. It develops NeuroLF, an ultra-compact dedicated brain PET system aimed at making brain imaging for dementia and Alzheimer's diagnosis more accessible to hospitals and clinics.

NeuroLF is a dedicated brain PET scanner that needs little space, is simple to operate and is designed for patient comfort. Applications listed include dementia, neuro-oncology, epilepsy, movement disorders and research. The system holds FDA clearance (July 2024) and CE marking (October 2024), is sold in the US and EU through direct sales and distributors, and is installed at sites such as LMU Klinikum in Munich and outpatient neurology clinics in the United States.

2. Highlighted features & specifications

  • Dedicated brain PET: ultra-compact scanner built only for brain imaging.
  • Dementia focus: designed for Alzheimer's and dementia diagnosis.
  • Broad applications: neuro-oncology, epilepsy, movement disorders and research.
  • Regulatory status: FDA clearance in July 2024 and CE mark in October 2024.
  • Quantitative harmonization: EARL accreditation achieved at LMU Klinikum Munich in 2026.
  • Distribution: distributors in Spain and France plus direct sales in the US and Germany.

3. Potential application

Neurology and nuclear medicine departments in Vietnamese central hospitals could use NeuroLF for dementia work-up. Research institutes could use it in Alzheimer's clinical studies. Private imaging centres could add brain-only PET with a smaller footprint.

4. Benefits

Small space requirements make brain PET feasible for sites without a full PET suite. Simple operation and patient comfort are highlighted. Specialists quoted on the site say it can lower the cost of brain scans. EARL accreditation supports quantitative comparability across sites.

6. Other information

Positrigo AG, Technoparkstrasse 1, 8005 Zurich, Switzerland. ISO 13485:2016 (2021 news), FDA clearance July 2024, CE mark October 2024. Financing round closed June 2025. Top 3 at the Swiss Medtech Award 2026. Distributors appointed in France and Spain in 2025; first Italian sale to the University Hospital of Genoa in December 2025.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us